Skip to main content
HSCS
NASDAQ Crypto Assets

Fortitude's Strong Q2 and $1M Stake in HeartSciences at a 22% Premium

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.52
Mkt Cap
$9.924M
52W Low
$1.63
52W High
$3.93
52W Position info
55% above low
Off High info
36% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HSCS sits 55% above its 52-week low of $1.63 on light trading volume (0.1× avg).

Summary

Fortitude Mining reported strong Q2 results and invested $1 million in HeartSciences at a 22% premium, reinforcing its commitment to the pending merger.


Key Events · M&A and Partnerships · HSCS

  • Fortitude Q2 Financials

    Fortitude reported Q2 2026 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, with 33,646 ZEC mined at an average hash rate of 4.0 GSol/s.

  • Private Placement Investment

    Fortitude purchased 411,522 shares of HeartSciences common stock for approximately $1.0 million at $2.43 per share, a 22% premium to the August 12 closing price.

  • Ownership Stake

    Following the subscription, Fortitude owns approximately 9.4% of HeartSciences' outstanding common stock, with no additional rights or preferences.

  • Merger Terms Unchanged

    The exchange ratio under the merger agreement remains unchanged, and Fortitude will not receive additional shares at closing as a result of the subscription.


Analysis · HSCS · Crypto Assets

Fortitude Mining, the merger partner of HeartSciences, disclosed Q2 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, demonstrating the operating strength of the business HeartSciences shareholders are being asked to acquire. More importantly, Fortitude purchased $1 million of HeartSciences stock at $2.43 per share — a 22% premium to the market price — signaling strong commitment to closing the deal and providing near-term operating capital. This investment gives Fortitude a 9.4% stake and does not alter the merger exchange ratio, so existing shareholders are not further diluted by this transaction. The filing comes amid HeartSciences' going-concern warning and Nasdaq delisting notice, making this capital infusion and vote of confidence a critical development for the pending merger.

How filings like this one have moved

In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HSCS was trading at $2.52 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.63 to $3.93. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSCS - Latest Insights

HSCS
Oct 06, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.77
Real-time Price: $3.08 info
Change: -$0.690 (-18%) info
Market Cap: $14.629M info
HSCS
Oct 06, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.82
Real-time Price: $3.08 info
Change: -$0.740 (-19%) info
Market Cap: $14.629M info
HSCS
Oct 06, 2026, 5:12 AM EDT
Source: CryptoProwl
Importance Score:
7
Price at Filing: $3.79
Real-time Price: $3.08 info
Change: -$0.710 (-19%) info
Market Cap: $14.629M info
HSCS
Oct 05, 2026, 6:10 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $4.38
Real-time Price: $3.08 info
Change: -$1.30 (-30%) info
Market Cap: $14.629M info
HSCS
Oct 05, 2026, 5:34 PM EDT
Filing Type: PRER14A
Importance Score:
9
Price at Filing: $3.70
Real-time Price: $3.08 info
Change: -$0.6205 (-17%) info
Market Cap: $14.629M info